Logo image of CS.PA

AXA SA (CS.PA) Stock Fundamental Analysis

EPA:CS - Euronext Paris - Matif - FR0000120628 - Common Stock - Currency: EUR

41.24  -1.09 (-2.58%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CS. CS was compared to 32 industry peers in the Insurance industry. CS has only an average score on both its financial health and profitability. CS has a correct valuation and a medium growth rate. CS also has an excellent dividend rating. These ratings would make CS suitable for dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CS had positive earnings in the past year.
In the past year CS had a positive cash flow from operations.
Each year in the past 5 years CS has been profitable.
In the past 5 years CS always reported a positive cash flow from operatings.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

CS's Return On Assets of 1.18% is fine compared to the rest of the industry. CS outperforms 62.50% of its industry peers.
With a decent Return On Equity value of 15.39%, CS is doing good in the industry, outperforming 65.63% of the companies in the same industry.
CS has a better Return On Invested Capital (1.33%) than 62.50% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CS is in line with the industry average of 2.19%.
The 3 year average ROIC (1.29%) for CS is below the current ROIC(1.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROIC 1.33%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CS has a Profit Margin (8.80%) which is in line with its industry peers.
CS's Profit Margin has improved in the last couple of years.
CS has a Operating Margin (12.32%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CS has grown nicely.
Industry RankSector Rank
OM 12.32%
PM (TTM) 8.8%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

CS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CS has less shares outstanding than it did 1 year ago.
CS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CS has a worse debt to assets ratio.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

Based on the Altman-Z score of 0.36, we must say that CS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CS (0.36) is better than 90.63% of its industry peers.
The Debt to FCF ratio of CS is 2.19, which is a good value as it means it would take CS, 2.19 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CS (2.19) is better than 75.00% of its industry peers.
CS has a Debt/Equity ratio of 0.53. This is a neutral value indicating CS is somewhat dependend on debt financing.
The Debt to Equity ratio of CS (0.53) is better than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Altman-Z 0.36
ROIC/WACC0.13
WACC10.54%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 0.87 indicates that CS may have some problems paying its short term obligations.
With an excellent Current ratio value of 0.87, CS belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
CS has a Quick Ratio of 0.87. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 0.87, CS belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.08% over the past year.
Measured over the past years, CS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.09% on average per year.
CS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.38%.
CS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.16% yearly.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%

3.2 Future

The Earnings Per Share is expected to grow by 6.32% on average over the next years.
Based on estimates for the next years, CS will show a small growth in Revenue. The Revenue will grow by 7.73% on average per year.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y6.32%
Revenue Next Year6%
Revenue Next 2Y5.31%
Revenue Next 3Y2.48%
Revenue Next 5Y7.73%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.49, which indicates a very decent valuation of CS.
Based on the Price/Earnings ratio, CS is valued a bit cheaper than the industry average as 71.88% of the companies are valued more expensively.
CS is valuated cheaply when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.30 indicates a reasonable valuation of CS.
Based on the Price/Forward Earnings ratio, CS is valued a bit cheaper than the industry average as 71.88% of the companies are valued more expensively.
CS is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.49
Fwd PE 10.3
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CS is valued a bit cheaper than the industry average as 65.63% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.62
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.99
PEG (5Y)0.64
EPS Next 2Y9.13%
EPS Next 3Y8.44%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.17%, CS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.68, CS pays a bit more dividend than its industry peers.
CS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 5.17%

5.2 History

The dividend of CS is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years3
Div Non Decr Years3
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CS pays out 57.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

AXA SA

EPA:CS (5/5/2025, 4:45:05 PM)

41.24

-1.09 (-2.58%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-19 2025-03-19/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners36.79%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap91.35B
Analysts80.74
Price Target43.3 (5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.17%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.93%
PT rev (3m)7.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.36%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)6.31%
Revenue NY rev (3m)11.84%
Valuation
Industry RankSector Rank
PE 11.49
Fwd PE 10.3
P/S 1.05
P/FCF 7.62
P/OCF 7.33
P/B 1.83
P/tB 3.34
EV/EBITDA N/A
EPS(TTM)3.59
EY8.71%
EPS(NY)4.01
Fwd EY9.71%
FCF(TTM)5.41
FCFY13.13%
OCF(TTM)5.63
OCFY13.65%
SpS39.43
BVpS22.55
TBVpS12.36
PEG (NY)0.99
PEG (5Y)0.64
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROCE 1.67%
ROIC 1.33%
ROICexc 1.37%
ROICexgc 1.79%
OM 12.32%
PM (TTM) 8.8%
GM N/A
FCFM 13.73%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.54%
Interest Coverage 1.72
Cash Conversion N/A
Profit Quality 156.03%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.36
F-Score7
WACC10.54%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y6.32%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year6%
Revenue Next 2Y5.31%
Revenue Next 3Y2.48%
Revenue Next 5Y7.73%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%